Kensey Nash buys adhesives specialist Nerites; Q2 sales down
This article was originally published in Clinica
Executive Summary
Kensey Nash has further fleshed out its regenerative biomaterials offering with the $20m acquisition of Nerites, a venture-backed surgical adhesives specialist.